BioChromato Inc reports how the renowned Chemistry Research Laboratories (CRL) at Oxford University (UK) are using several Smart Evaporator C1 units to support their drug discovery activities in therapeutic areas including oncology and regenerative medicine.

Paperpal Preflight leverages AI and machine learning to support authors and journal editors during manuscript submission process.

Biotech Support Group and Leiden University Medical Center announce publication of a journal article based upon on their joint goal to correlate BSG’s patent pending Stroma Liquid Biopsy™ panel of blood-borne biomarkers, to tissue derived tumor-stroma ratio scoring methods.

Global provider of human and animal biospecimens - AMSBIO offers a custom procurement service enabling researchers to source specific biofluid and tissue samples which are not already available in their extensive biorepository.

Eppendorf SE has donated 20,000 euros to the European Molecular Biology Laboratory (EMBL) during an online presentation ceremony. The funds are for the EMBL project “Advancement of Women in Science,” which enables women scientists to begin managerial careers in scientific fields.

Thermo Fisher Scientific, the world leader in serving science, has introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

RareCan a novel company accelerating research into rare cancers, has announced it has received approval from the NHS Research Ethics Committee to establish its BioResource at Newcastle University.

Companies announce an agreement to co-market products together to improve robust, high-throughput proteomics workflows for precision medicine.

Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types.

AMSBIO have supplied custom Chimeric antigen receptor (CAR)-T products to the University of Strathclyde (UoS) in Glasgow, UK, and ScreenIn3D Ltd, allowing them to perform novel immune-oncology assays in 3D microfluidic cancer models.